Evidence map›Paper›PMID 39859417›Full record

ArticleInternational journal of molecular sciences2025

Liquid-Based Diagnostic Panels for Prostate Cancer: The Synergistic Role of Soluble PD-L1, PD-1, and mRNA Biomarkers.

Margarita Žvirblė, Ieva Vaicekauskaitė, Žilvinas Survila, Paulius Bosas, Neringa Dobrovolskienė, Agata Mlynska, Rasa Sabaliauskaitė, Vita Pašukonienė

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Margarita ŽvirblėNational Cancer Institute, P. Baublio Str. 3B, LT-08406 Vilnius, Lithuania.ORCID 0000-0002-4598-0108
Ieva VaicekauskaitėNational Cancer Institute, P. Baublio Str. 3B, LT-08406 Vilnius, Lithuania.ORCID 0000-0003-3536-4384
Žilvinas SurvilaInstitute of Biosciences, Life Sciences Center Vilnius University, Saulėtekio av 7, LT-10257 Vilnius, Lithuania.
Paulius BosasNational Cancer Institute, P. Baublio Str. 3B, LT-08406 Vilnius, Lithuania.ORCID 0000-0002-4951-1122
Neringa DobrovolskienėNational Cancer Institute, P. Baublio Str. 3B, LT-08406 Vilnius, Lithuania.ORCID 0000-0001-8044-8910
Agata MlynskaNational Cancer Institute, P. Baublio Str. 3B, LT-08406 Vilnius, Lithuania.ORCID 0000-0002-3646-0258
Rasa SabaliauskaitėNational Cancer Institute, P. Baublio Str. 3B, LT-08406 Vilnius, Lithuania.ORCID 0000-0002-3465-3558
Vita PašukonienėNational Cancer Institute, P. Baublio Str. 3B, LT-08406 Vilnius, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the diagnostic potential of soluble Programmed Death Ligand 1 (sPD-L1) and Programmed Death 1 (sPD-1) molecules in plasma, along with urinary mRNA biomarkers-Prostate-Specific Membrane Antigen (

Indexed as

B7-H1 AntigenBiomarkers, TumorProgrammed Cell Death 1 ReceptorProstatic NeoplasmsRNA, MessengerAgedAntigens, NeoplasmAntigens, SurfaceGlutamate Carboxypeptidase IIHumansMaleMiddle AgedReceptors, AndrogenROC CurveAntigens, NeoplasmAntigens, SurfaceB7-H1 AntigenBiomarkers, TumorCD274 protein, humanFOLH1 protein, humanGlutamate Carboxypeptidase IIPDCD1 protein, humanProgrammed Cell Death 1 Receptorprostate cancer antigen 3, humanReceptors, AndrogenRNA, Messengercirculating moleculesliquid biopsymRNA transcriptsprostate cancersPD-1sPD-L1

Identifiers

PMID39859417
PMCPMC11765789

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.